Thus, aptamer sgc8c could not only help TDNs entry into the cell but also specifically target on PTK7‐positive cells (CCRF‐CEM), indicative of its potential application for the drug delivery of PTK7‐positive tumours. This evidence concerns the gene PTK7 and neoplasm.